About Us

Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
My Watchlist
Indicators
Local Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
Sicily's sustainable soul revealed through slow travel / Earthquake sites, climb to Erice among many out-of-the-ordinary proposals
Via PR Leap
Topics Product Recall
Exposures Legal Product Safety
News headline image
1 Top Penny Stock to Watch Now
Via Barchart.com
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
News headline image
California Trim Clinic Explains the Smarter Safer Path to Peptide Therapy
Via PRUnderground
Exposures Product Safety
News headline image
New Moment of Clarity Resource Examines How Insurance Covers Ketamine Therapy
Via Press Advantage
Exposures Product Safety
Disc Medicine, Sanofi, Eli Lilly Shares Slip On Reports Of FDA Increasing Review Time For Drugs Granted Priority Review Vouchers ↗
Via Stocktwits
Tickers IRON LLY SNY
Exposures Product Safety
News headline image
AXSM Stock Rises After Analyst Hikes Price Target On Auvelity Drug Optimism ↗
Via Stocktwits
Topics Artificial Intelligence
Tickers AXSM GS
Exposures Artificial Intelligence Product Safety
News headline image
Las Vegas Eye Institute Introduces Ray-Traced LASIK: A New Era of Personalized Vision Correction
Via Press Advantage
Exposures Product Safety
News headline image
The New Diagnostic Sentinel: Samsung and Stanford’s AI Redefines Early Dementia Detection via Wearable Data
Via TokenRing AI
Topics Artificial Intelligence
Tickers AAPL FIT GOOGL SSNLF
Exposures Artificial Intelligence Product Safety
News headline image
Prediction Markets Hit the Big Leagues: Kalshi Secures $1 Billion at $11 Billion Valuation to ‘Financialize Everything’
Via PredictStreet
Topics Derivatives Economy Initial Public Offering
Tickers ARKK GOOGL HOOD
Exposures Derivatives Economy Interest Rates
News headline image
Why ImmunityBio Stock Is Skyrocketing Again Today ↗
Via The Motley Fool
Tickers IBRX
Exposures Product Safety
News headline image
Disc Medicine Analyst Remains Confident In Rare Disease Drug Despite FDA Action ↗
Via Benzinga
Exposures Product Safety
News headline image
ImmunityBio Stock Soars On Cancer Trial Progress, FDA Timeline ↗
Via Benzinga
Exposures Product Safety
News headline image
NVS Stock Rises After FDA Grants Breakthrough Therapy Designation For Autoimmune Disorder Treatment ↗
Via Stocktwits
Tickers APIE DFAX NVS
Exposures Product Safety
News headline image
Hemostemix Receives FDA Support for Its Basket Protocol Approach
Via Newsfile
Tickers HMTXF TSX-V:HEM
Exposures Product Safety
News headline image
The Truth Engine: How Prediction Markets Became the New Foundation for Global Capital
Via PredictStreet
Topics Artificial Intelligence Bonds Derivatives
Tickers COIN HOOD ICE
Exposures Artificial Intelligence Debt Markets Derivatives
News headline image
Kaplan Fox & Kilsheimer LLP is Investigating Aquestive Therapeutics, Inc. (AQST) for Potential Securities Law Violations
Via NewMediaWire
Tickers AQST
Exposures Product Safety
News headline image
Kaplan Fox &amp; Kilsheimer LLP is Investigating Aquestive Therapeutics, Inc. (AQST) for Potential Securities Law Violations
Via TheNewswire.com
Tickers AQST
Exposures Product Safety
News headline image
S&P 500 Ascends to Historic Peaks: Stimulus and AI Rebound Fuel January Rally
Via MarketMinute
Topics Artificial Intelligence Earnings Economy
Tickers AAPL BAC DELL FIVE GM GOOGL
Exposures Artificial Intelligence Economy Financial
News headline image
Lululemon at the Crossroads: Analyzing the 2026 Leadership Crisis and the Post-Sun Choe Era
Via Finterra
Topics Economy Intellectual Property Product Recall
Tickers ADDYY DECK LULU NKE ONON
Exposures COVID-19 Coal Intellectual Property
News headline image
The mRNA 2.0 Inflection: A Deep Dive into Moderna (MRNA) as it Faces a Critical 2026
Via Finterra
Topics Initial Public Offering Intellectual Property Lawsuit
Tickers ABUS BAYRY GSK MRK MRNA PFE
Exposures COVID-19 Financial Intellectual Property
News headline image
Why This Horrible Ford Record Is Important for Investors ↗
Via The Motley Fool
Topics Product Recall
Tickers F GM
Exposures Legal Product Safety
News headline image
Why Did ATOS Stock Jump 10% In Pre-Market Today? ↗
Via Stocktwits
Tickers ATOS VTI VXF
Exposures Product Safety
News headline image
Global Development Accelerates: Leads Biolabs' PD-L1/4-1BB Bispecific Antibody Granted Fast Track Designation by FDA
Via Newsfile
Exposures Product Safety
News headline image
Moonkie Redefines Toddler Mealtime with Launch of Award-Nominated Stainless Steel Silicone Suction Bowl
Via Get News
Topics Bonds
Exposures Debt Markets Product Safety
News headline image
Baskin Aesthetics Reveals Insights on Bioidentical Hormone Therapy Following Recent FDA Updates on Menopausal Treatments
Via Press Advantage
Exposures Product Safety
News headline image
Eli Lilly’s $1.2 Billion Acquisition of Ventyx Biosciences: Bridging the Gap Between Weight Loss and Chronic Inflammation
Via MarketMinute
Topics Intellectual Property
Tickers LLY NVO SNY VTYX
Exposures Intellectual Property Product Safety
News headline image
A US Startup Achieves Rapid Business Growth by Purchasing Toptrue Insulated Water Bottles
Via AB Newswire
Topics Economy Supply Chain
Exposures Product Safety Supply Chain
News headline image
Top 8 Huber Needle Manufacturers and suppliers in China 2026
Via AB Newswire
Topics Supply Chain
Exposures Product Safety Supply Chain
News headline image
Scientific Instruments Shares How Ignoring Magnaflux Equipment Repairs Can Lead to Missed Defects and Costly Recalls
Via ReleaseWire
Topics Product Recall
Exposures Legal Product Safety
News headline image
Becton, Dickinson Wins FDA Clearance For Next-Gen Breast Biopsy Device, Launch Set For 2026 ↗
Via Benzinga
Exposures Product Safety
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.